Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry-Reference-Cited by-同舟云学术

Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry

Published:2016-07-14 Issue:1 Volume:89 Page:47-56
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Naganuma Toru¹²,Colombo Antonio¹,Lesiak Maciej³,Capodanno Davide⁴,Gori Tommaso⁵,Nef Holger⁶,Caramanno Giuseppe⁷,Naber Christoph⁸,Di Mario Carlo⁹,Ruparelia Neil¹,Capranzano Piera⁴,Wiebe Jens⁶,Araszkiewicz Aleksander³,Geraci Salvatore⁷,Kawamoto Hiroyoshi¹²,Pyxaras Stelios⁸,Mattesini Alessio⁹,Münzel Thomas⁵,Tamburino Corrado⁴,Latib Azeem¹

Affiliation:

1. EMO-GVM Centro Cuore and San Raffaele Hospitals; Milan Italy

2. New Tokyo Hospital; Chiba Japan

3. Department of Cardiology; University of Medical Sciences; Poznan Poland

4. Ferrarotto Hospital, University of Catania; Catania Italy

5. Medizinische Klinik Und Poliklinik, Universitätsmedizin Mainz, University Medical Center; Mainz Germany

6. Department of Cardiology; University of Giessen; Giessen Germany

7. San Giovanni Di Dio Hospital; Agrigento Italy

8. Klinik Für Kardiologie Und Angiologie, Elisabeth-Krankenhaus; Essen Germany

9. National Institute of Health Research Cardiovascular BRU; Royal Brompton Hospital and Imperial College; London United Kingdom

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Reference30 articles.

1. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial;Serruys;Lancet,2015

2. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: Early and midterm outcomes from the European multicentre GHOST-EU registry;Capodanno;EuroIntervention,2014

3. Everolimus-eluting bioresorbable scaffolds for coronary artery disease;Ellis;N Engl J Med,2015

4. Looking into the future with bioresorbable vascular scaffolds;Costopoulos;Expert Rev Cardiovasc Ther,2013

5. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study;Vaquerizo;EuroIntervention,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The COBRA II (COmplex Bifurcation lesions: RAndomized comparison of a fully bioresorbable modified-T stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds) study: Final 5-year follow-up;Indian Heart Journal;2023-11

2. Safety and Efficacy of Bioresorbable Vascular Scaffolds in Coronary Bifurcation Lesions: A Systematic Review and Meta-Analysis;Current Cardiology Reviews;2022-11

3. Impact of directional coronary atherectomy followed by drug-coated balloon strategy to avoid the complex stenting for bifurcation lesions;Heart and Vessels;2022-01-04

4. Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study;Catheterization and Cardiovascular Interventions;2021-12-30

5. Lesion impacts on long-term outcomes in patients implanted with bioresorbable vascular scaffold;Journal of the Formosan Medical Association;2021-11